| Microbial translocation is a cause of systemic immune activation in chronic HIV infection JM Brenchley, DA Price, TW Schacker, TE Asher, G Silvestri, S Rao, ... Nature medicine 12 (12), 1365, 2006 | 3208 | 2006 |
| Effect of early versus deferred antiretroviral therapy for HIV on survival MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ... New England Journal of Medicine 360 (18), 1815-1826, 2009 | 1401 | 2009 |
| The end of AIDS: HIV infection as a chronic disease SG Deeks, SR Lewin, DV Havlir The Lancet 382 (9903), 1525-1533, 2013 | 1109 | 2013 |
| HIV infection, inflammation, immunosenescence, and aging SG Deeks Annual review of medicine 62, 141-155, 2011 | 988 | 2011 |
| HIV-1 protease inhibitors: a review for clinicians SG Deeks, M Smith, M Holodniy, JO Kahn Jama 277 (2), 145-153, 1997 | 933 | 1997 |
| Plasma levels of soluble CD14 independently predict mortality in HIV infection NG Sandler, H Wand, A Roque, M Law, MC Nason, DE Nixon, ... Journal of Infectious Diseases 203 (6), 780-790, 2011 | 869 | 2011 |
| Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load SG Deeks, CMR Kitchen, L Liu, H Guo, R Gascon, AB Narváez, P Hunt, ... Blood 104 (4), 942-947, 2004 | 847 | 2004 |
| T Cell Activation Is Associated with Lower CD4+ T Cell Gains in Human Immunodeficiency Virus-Infected Patients with Sustained Viral Suppression during … PW Hunt, JN Martin, E Sinclair, B Bredt, E Hagos, H Lampiris, SG Deeks The Journal of infectious diseases 187 (10), 1534-1543, 2003 | 811 | 2003 |
| Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia SG Deeks, T Wrin, T Liegler, R Hoh, M Hayden, JD Barbour, NS Hellmann, ... New England Journal of Medicine 344 (7), 472-480, 2001 | 803 | 2001 |
| Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy SG Deeks, BD Walker Immunity 27 (3), 406-416, 2007 | 724 | 2007 |
| Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 MP Martin, Y Qi, X Gao, E Yamada, JN Martin, F Pereyra, S Colombo, ... Nature genetics 39 (6), 733, 2007 | 695 | 2007 |
| Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans M Hellerstein, MB Hanley, D Cesar, S Siler, C Papageorgopoulos, ... Nature medicine 5 (1), 83, 1999 | 694 | 1999 |
| Relationship between T Cell Activation and CD4+ T Cell Count in HIV-Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy PW Hunt, J Brenchley, E Sinclair, JM McCune, M Roland, KP Shafer, ... The Journal of infectious diseases 197 (1), 126-133, 2008 | 647 | 2008 |
| HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity SG Deeks, AN Phillips Bmj 338, a3172, 2009 | 641 | 2009 |
| Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection PY Hsue, JC Lo, A Franklin, AF Bolger, JN Martin, SG Deeks, DD Waters Circulation 109 (13), 1603-1608, 2004 | 615 | 2004 |
| Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection W Jiang, MM Lederman, P Hunt, SF Sieg, K Haley, B Rodriguez, ... The Journal of infectious diseases 199 (8), 1177-1185, 2009 | 591 | 2009 |
| Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis LA Napolitano, RM Grant, SG Deeks, D Schmidt, SC De Rosa, ... Nature medicine 7 (1), 73, 2001 | 589 | 2001 |
| HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy SG Deeks, FM Hecht, M Swanson, T Elbeik, R Loftus, PT Cohen, ... Aids 13 (6), F35-F43, 1999 | 474 | 1999 |
| Towards an HIV cure: a global scientific strategy SG Deeks, B Autran, B Berkhout, M Benkirane, S Cairns, N Chomont, ... Nature reviews Immunology 12 (8), 607, 2012 | 472 | 2012 |
| Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells J Scholler, TL Brady, G Binder-Scholl, WT Hwang, G Plesa, KM Hege, ... Science translational medicine 4 (132), 132ra53-132ra53, 2012 | 455 | 2012 |
